Oct 7, 2005 by Stephen D. SimpsonNothing Seedy About UAPAlthough agriculture is not really a growth industry, this well-run supplier is generating solid returns on capital.
Oct 7, 2005 by Stephen D. SimpsonAmped About CalAmpA strong quarter has investors feeling optimistic about this wireless-equipment maker.
Oct 7, 2005 by Stephen D. SimpsonSalvaging Growth at SchnitzerThe company is in a tough commodity business, but sound management could still mean above-average opportunity.
Oct 7, 2005 by Stephen D. SimpsonSame Old UTStarcomWill this company ever actually achieve an in-line, excuse-free quarter?
Oct 6, 2005 by Stephen D. SimpsonRaw Materials Keep RPM IdlingHigh raw material costs are keeping a lid on growth at RPM.
Oct 6, 2005 by Stephen D. SimpsonCardioDynamics' Pulse FadingThe products from this small-cap medical technology company work. It's simply not selling enough of them.
Oct 6, 2005 by Stephen D. SimpsonShedding Light on Acuity BrandsThis modestly sized lighting and chemicals company might be a bargain hiding in the shadows.
Oct 6, 2005 by Stephen D. SimpsonSolectron Needs a SparkA strong balance sheet makes Solectron a turnaround candidate, but revived telecom spending will be key.
Oct 6, 2005 by Stephen D. SimpsonCan Ruby Tuesday Sparkle Again?Easier comps might give Ruby Tuesday the appearance of outperformance in the coming year.
Oct 5, 2005 by Stephen D. SimpsonFat Profits From DietingStrong growth has fueled an incredible one-year rise for this weight-management company.
Oct 5, 2005 by Stephen D. SimpsonWright Goes WrongA weak third quarter compounds troubles for this pipeline-challenged orthopedics player.
Oct 5, 2005 by Stephen D. SimpsonWolverine: Mighty MustelidWolverine isn't posting go-go growth, and long-term oriented investors should be just fine with that.
Oct 5, 2005 by Stephen D. SimpsonADC Needs More FiberA shortfall in second-half demand for fiber equipment trips up the turnaround of this once high-flying communications equipment vendor.
Oct 5, 2005 by Stephen D. SimpsonLupus Trials Spook InvestorsLupus is a high-risk, high-reward indication, and today's disappointing trial results aren't the end of the story for Human Genome Sciences.
Oct 4, 2005 by Stephen D. SimpsonThe Gray Picture for CloroxHigher expenses are going to start hurting profits, while higher prices might curtail growth.
Oct 4, 2005 by Stephen D. SimpsonLexmark's Guidance Looks SpottyA big quarterly miss and dour guidance plague an otherwise good company.
Oct 4, 2005 by Stephen D. SimpsonChesapeake's Movin' On UpWith the purchase of Columbia Natural Resources, Chesapeake now stands as the third-largest gas producer in the U.S.
Oct 3, 2005 by Stephen D. SimpsonNRG Boosts Its JuiceAcquiring Texas Genco should make NRG a more efficient and effective operator.
Oct 3, 2005 by Stephen D. SimpsonBritish Cable Giants Hook UpA long-rumored deal comes to fruition as Britain's two leading cable companies combine.
Oct 3, 2005 by Stephen D. SimpsonClipper Loses Its CaptainsThe near-legendary Clipper Fund's founding managers sail into the sunset.
